MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Body position during sleep in patients with Parkinson’s disease (PD): A sensor-based analysis

    J. Sringean, P. Taechalertpaisarn, C. Thanawattano, R. Bhidayasiri (Nonthaburi, Thailand)

    Objective: To identify the body position during sleep in PD patients in comparison to their spouses by using multisite wearable inertial sensors. Background: Nocturnal hypokinesia…
  • 2016 International Congress

    The Parkinson progression marker initiative (PPMI) – Developing a comprehensive longitudinal biomarker dataset

    Parkinson Progression Marker Initiative (New Haven, CT, USA)

    Objective: The goal of the Parkinson Progression Marker Initiative (PPMI) is to identify clinical, imaging and biospecimen biomarkers of PD progression to provide tools for…
  • 2016 International Congress

    Cognitive behavioural thrapy and adiunctive physical therapy for functional movement disorders

    R. Erro, M. Tinazzi, C. Dallocchio (London, United Kingdom)

    Objective: To test the feasibility and efficacy of Cognitive Behavioural Therapy (CBT) and Adjunctive Physical Therapy (APA) APA in Functional Movement Disorders (FMD). Background: Functional…
  • 2016 International Congress

    KINECT 3: A randomized, double-blind, placebo-controlled phase 3 trial of valbenazine (NBI-98854) for tardive dyskinesia

    S.A. Factor, R.A. Hauser, S. Siegert, G.S. Liang, C.F. O'Brien (Atlanta, GA, USA)

    Objective: To assess the efficacy, safety and tolerability of valbenazine (NBI-98854) for Tardive Dyskinesia (TD). Background: Tardive dyskinesia (TD) is a persistent and often disabling…
  • 2016 International Congress

    Risk factors for premature withdraw from the LS-1 PD study

    J.Y. Fang, S. Luo, M. Huang, R.B. Dewey, R. Hauser, G. Chen (Nashville, TN, USA)

    Objective: To identify risk factors for premature withdrawal from a large, multi-center Parkinson's disease clinical trial of possible neuroprotection. Background: Premature withdrawal (PW) of subjects…
  • 2016 International Congress

    Effect of frequency modulation on freezing of gait in PD patients after bilateral STN DBS

    R.M. Kandadai, V.V.P. Kagita, S.A. Jabeen, A.K. Puligopu, M.A. Kanikannan, R. Borgohain (Hyderabad, India)

    Objective: To study various frequency settings and to identify the optimal frequency of bilateral subthalamic nuclei deep brain stimulation (DBS) for improvement in gait in…
  • 2016 International Congress

    Does body mass index influence outcome of deep brain stimulation in Parkinson’s patients?

    H. Abboud, G. Genc, D. Reyes, N.R. Thompson, R. Cerejo, K. Wilson, A. Ahmed, M. Gostkowski, A. Machado, H.H. Fernandez (Cleveland, OH, USA)

    Objective: To investigate if preoperative body mass index (BMI) can predict functional and quality of life (QOL) outcomes following deep brain stimulation surgery (DBS) in…
  • 2016 International Congress

    Morbidity and comorbidity of deep brain stimulation for Parkinson’s disease – A thirteen-years retrospective cohort study

    S.Y. Chen, Y.H. Pan, S.H. Lin (Hualien, Taiwan)

    Objective: To assess the surgical morbidity and comorbidity in 140 consecutive patients with various disease entities of movement disorders, epilepsy and obsessive-compulsive disorders that underwent…
  • 2016 International Congress

    A dopamine-dependent activity of the STN in the control of balance in Parkinson’s disease

    G. Arnulfo, N.G. Pozzi, C. Palmisano, A. Canessa, J. Brumberg, C.A. Frigo, G. Pezzoli, F. Steigerwald, J. Volkmann, I.U. Isaias (Würzburg, Germany)

    Objective: To investigate the activity of the subthalamic nucleus (STN), and its relation to nigro-striatal dopaminergic denervation, in control of balance in Parkinson's disease (PD).…
  • 2016 International Congress

    Implantable pulse generator (IPG) longevity decreases following each replacement surgery in Parkinson’s disease (PD) patients treated with bilateral sub-thalamic nucleus deep brain stimulation (STN-DBS)

    S.D. Israeli-Korn, S. Tessler, G. Yahalom, S. Benizri, O.S. Cohen, C. Shabat, H. Strauss, N. Warmann-Alaluf, E. Stein, Z. Zibly, R. Spiegelman, S. Hassin (Ramat Gan, Israel)

    Objective: To investigate the influence of the number of implantable pulse generator (IPG) replacement surgeries and the IPG model on battery life in bilateral STN…
  • « Previous Page
  • 1
  • …
  • 128
  • 129
  • 130
  • 131
  • 132
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley